| 000 | 01581 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518033351.0 | ||
| 264 | 0 | _c20200817 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/ene.13961 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXie, X | |
| 245 | 0 | 0 |
_aEffect of dual versus mono antiplatelet therapy on recurrent stroke modulated by activated partial thromboplastin time. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _c09 2019 |
||
| 300 |
_a1168-e78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 |
_aBrain Ischemia _xprevention & control |
| 650 | 0 | 4 |
_aClopidogrel _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aStroke _xprevention & control |
| 700 | 1 | _aWang, X | |
| 700 | 1 | _aLaskowitz, D T | |
| 700 | 1 | _aZhao, X | |
| 700 | 1 | _aMiao, Z | |
| 700 | 1 | _aLiu, L | |
| 700 | 1 | _aLi, H | |
| 700 | 1 | _aMeng, X | |
| 700 | 1 | _aWang, Y | |
| 700 | 1 | _aWang, Y | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 26 _gno. 9 _gp. 1168-e78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ene.13961 _zAvailable from publisher's website |
| 999 |
_c29576730 _d29576730 |
||